Literature DB >> 25354464

Intranasal oxytocin and NSAIDs : Comment on: Oxytocin nasal spray in fibromyalgic patients (Rheumatol Int. 2014 Aug;34(8):1047-52.).

Kenneth K Kwong1, Suk-tak Chan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25354464      PMCID: PMC4409468          DOI: 10.1007/s00296-014-3163-3

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


× No keyword cloud information.
  15 in total

1.  The variation in chronic widespread pain and other symptoms in fibromyalgia patients. The effects of menses and menopause.

Authors:  O N Pamuk; N Cakir
Journal:  Clin Exp Rheumatol       Date:  2005 Nov-Dec       Impact factor: 4.473

2.  [Decreased pain sensitivity in man after treatment with superlow doses of oxytocin].

Authors:  Iu V Uryvaev; G A Petrov
Journal:  Biull Eksp Biol Med       Date:  1996-11

3.  Oxytocin nasal spray in fibromyalgic patients: additional information : reply to the comment to the editor entitled "future directions for the investigation of intranasal oxytocin and pain".

Authors:  Roberta Agabio; Sergio Mameli; Salvatore Sardo; Luigi Minerba; Maria Rosaria Melis
Journal:  Rheumatol Int       Date:  2014-07-29       Impact factor: 2.631

4.  Effects of long-term treatment with oxytocin in chronic constipation; a double blind, placebo-controlled pilot trial.

Authors:  B Ohlsson; M Truedsson; M Bengtsson; R Torstenson; K Sjölund; E S Björnsson; M Simrèn
Journal:  Neurogastroenterol Motil       Date:  2005-10       Impact factor: 3.598

5.  Plasma oxytocin levels in female fibromyalgia syndrome patients.

Authors:  U M Anderberg; K Uvnäs-Moberg
Journal:  Z Rheumatol       Date:  2000-12       Impact factor: 1.372

6.  Menstrual cycle-related changes in plasma oxytocin are relevant to normal sexual function in healthy women.

Authors:  Andrea Salonia; Rossella E Nappi; Marina Pontillo; Rita Daverio; Antonella Smeraldi; Alberto Briganti; Fabio Fabbri; Giuseppe Zanni; Patrizio Rigatti; Francesco Montorsi
Journal:  Horm Behav       Date:  2004-12-09       Impact factor: 3.587

7.  Oxytocin plasma concentrations after single intranasal oxytocin administration - a study in healthy men.

Authors:  A Gossen; A Hahn; L Westphal; S Prinz; R T Schultz; G Gründer; K N Spreckelmeyer
Journal:  Neuropeptides       Date:  2012-08-11       Impact factor: 3.286

8.  The interaction between the oxytocin and pain modulation in headache patients.

Authors:  Yong-Liang Wang; Yan Yuan; Jun Yang; Chang-Hong Wang; Yan-Juan Pan; Lu Lu; Yu-Quan Wu; Da-Xin Wang; Lu-Xian Lv; Ren-Ren Li; Lei Xue; Xin-Hua Wang; Jian-Wei Bi; Xin-Feng Liu; Yan-Ning Qian; Zhi-Kuan Deng; Zhi-Jian Zhang; Xin-Huan Zhai; Xin-Jian Zhou; Guo-Liang Wang; Jian-Xin Zhai; Wen-Yan Liu
Journal:  Neuropeptides       Date:  2013-01-30       Impact factor: 3.286

9.  Expression and developmental regulation of oxytocin (OT) and oxytocin receptors (OTR) in the enteric nervous system (ENS) and intestinal epithelium.

Authors:  Martha G Welch; Hadassah Tamir; Kara J Gross; Jason Chen; Muhammad Anwar; Michael D Gershon
Journal:  J Comp Neurol       Date:  2009-01-10       Impact factor: 3.215

10.  Effects of oxytocin and prosocial behavior on brain responses to direct and vicariously experienced pain.

Authors:  Tania Singer; Romana Snozzi; Geoffrey Bird; Predrag Petrovic; Giorgia Silani; Markus Heinrichs; Raymond J Dolan
Journal:  Emotion       Date:  2008-12
View more
  3 in total

1.  The lack of efficacy of oxytocin and NSAIDs.

Authors:  Roberta Agabio; Sergio Mameli; Maria Rosaria Melis
Journal:  Rheumatol Int       Date:  2015-01-15       Impact factor: 2.631

Review 2.  Musculoskeletal Pain and Brain Morphology: Oxytocin's Potential as a Treatment for Chronic Pain in Aging.

Authors:  Désirée Lussier; Yenisel Cruz-Almeida; Natalie C Ebner
Journal:  Front Aging Neurosci       Date:  2019-12-13       Impact factor: 5.750

3.  Effects of fibromyalgia on the disease activity and treatment of patients with axial spondyloarthritis.

Authors:  Ruoxi Gao
Journal:  J Musculoskelet Neuronal Interact       Date:  2021-09-01       Impact factor: 2.041

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.